Please login to the form below

Not currently logged in
Email:
Password:

Life restructure sees management reshuffle

Reg Manser leaves creative director post to take up chief creative officer role

Life Steve Martin Elinor Washbrook Ben Dragon 
Pictured (left to right): Steve Martin, Elinor Washbrook and Ben Dragon  

Windsor, UK-based healthcare advertising agency Life has restructured its operations in a move that sees several senior changes.  

Heading these up is Reg Manser, who steps down as the agency's creative director in order to assume the role of chief creative officer.  

As CCO he will work alongside Life CEO Juliet La Marque on the company's creative strategy and business development.  

In this position Manser will be supported by Matt Leeming, who assumes the newly-created position of strategy director, advising clients on marketing strategy and brand development.  

Taking over as creative director is Steve Martin, who brings to the role big-brand experience gained in major consumer agencies as well as nearly a decade in pharmaceutical advertising.  

Martin will be supported by Elinor Washbrook, who is promoted to head of copy and will manage Life's team of medical copywriters.  

Life, which said the changes reflect its role as an integrated creative communications agency, rounds out its changes by appointing Ben Dragon as head of art to oversee the agency's design output.

9th October 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....